Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,748.00    -12.00 (-0.32%)
Bid:
3,748.00
Ask:
3,752.00
Spread: 4.00 (0.107%)
Market Cap: £1.05b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Update on Current Trading

30 Oct 2020 07:00

RNS Number : 6839D
4imprint Group PLC
30 October 2020
 

30 October 2020

4imprint Group plc ("4imprint" or the "Group")

Update on Current Trading

 

4imprint today provides an update on the Group's trading and operations.

 

Encouraging progress has been made in dealing with the continuing disruptive effects on the business of the COVID-19 pandemic. In the Group's half year results, announced on 13 August 2020, we noted that weekly order intake had recovered to a run rate of just above 50% of prior year from a low in April of less than 20%. Recent experience has seen further improvement, with average weekly order intake running at just above 60% of prior year level over the last four weeks. Average order values have continued to run higher than historical comparatives, resulting in average weekly revenue over the same four week period of around 65% of prior year.

 

The apparel category has performed well compared to other categories during the pandemic. Decorated apparel unit volume at the Oshkosh Distribution Centre is now running at close to prior year level and, as a result, the utilisation of permanent labour capacity has now returned to 100%.

 

We continue to acquire new customers at a relatively promising rate, with the new-to-existing customer ratio running in a stable band. This customer activity has been driven by a careful and precise re-introduction and reallocation of marketing funds, particularly towards our brand marketing programme.

 

Every effort is being made to manage the effects of the pandemic throughout our operations. Strong safety and social distancing protocols are being observed in all of our facilities. Wherever practical, our office-based team members are still working from home.

 

The Group remains in a strong financial position, with a cash balance of $40.1m at the October 2020 accounting month end and no debt.

 

Although we have seen encouraging signs in recent weeks, the inherent uncertainty resulting from the COVID-19 situation means that it is too early to provide any forward guidance at this point. We do, however, remain very confident in the Group's strategy, business model, competitive positioning and ultimately our ability to deliver sustainable value for all stakeholders.

 

 

 

 

 

For further information, please contact:

 

4imprint Group plc

Tel. + 44 (0) 20 3709 9680

MHP Communications

Tel. + 44 (0) 20 3128 8549 / +44 (0) 7585 301464

 

Kevin Lyons-Tarr, Chief Executive Officer

 

David Seekings, Chief Financial Officer

Katie Hunt

 

Rachel Mann

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFEFFWUESSEIS
Date   Source Headline
21st Nov 20089:25 amRNSDirector/PDMR Shareholding
28th Oct 20086:16 pmRNSHolding(s) in Company
27th Oct 20087:00 amRNSInterim Management Statement
21st Aug 20083:48 pmRNSHolding(s) in Company
21st Aug 20083:07 pmRNSHolding(s) in Company
11th Aug 20084:31 pmRNSHolding(s) in Company
7th Aug 20087:00 amRNSInterim Results
28th Jul 20083:34 pmRNSHolding(s) in Company
27th Jun 20085:25 pmRNSDirector/PDMR Shareholding
26th Jun 20087:00 amRNSTrading Statement
28th May 20084:08 pmRNSPrice Monitoring Extension
28th May 20084:02 pmRNSPrice Monitoring Extension
28th May 20083:58 pmRNSPrice Monitoring Extension
12th May 20084:00 pmRNSHolding(s) in Company
23rd Apr 200811:00 amRNSAGM Statement
7th Apr 20083:47 pmRNSRule 8.3- 4imprint PLC-Amend
7th Apr 20082:20 pmRNSRule 8.3- 4Imprint
28th Mar 20085:53 pmRNSHolding(s) in Company
13th Mar 20085:35 pmRNSHolding(s) in Company
5th Mar 20084:43 pmRNSDirector/PDMR Shareholding
4th Mar 20087:01 amRNSFinal Results
29th Feb 20087:00 amRNSHolding(s) in Company
28th Feb 20082:13 pmRNSHolding(s) in Company
7th Feb 20083:44 pmRNSHolding(s) in Company
5th Feb 20083:15 pmRNSHolding(s) in Company
5th Feb 20088:50 amRNSHolding(s) in Company
4th Feb 20085:34 pmRNSHolding(s) in Company
4th Feb 20085:09 pmRNSHolding(s) in Company
31st Jan 20081:01 pmRNSHolding(s) in Company
31st Jan 20089:36 amRNSHolding(s) in Company
31st Jan 20089:14 amRNSHolding(s) in Company
30th Jan 20081:00 pmRNSHolding(s) in Company
17th Jan 200811:40 amRNSHolding(s) in Company
10th Jan 200812:51 pmRNSHolding(s) in Company
10th Jan 200812:46 pmRNSHolding(s) in Company
8th Jan 200812:00 pmRNSHolding(s) in Company
7th Jan 20083:17 pmRNSHolding(s) in Company
4th Jan 200811:42 amRNSHolding(s) in Company
4th Jan 200810:10 amRNSHolding(s) in Company
3rd Jan 200811:46 amRNSHolding(s) in Company
19th Dec 20074:35 pmRNSPrice Monitoring Extension
18th Dec 20076:21 pmRNSHolding(s) in Company
18th Dec 20073:26 pmRNSTrading Statement
17th Dec 20073:48 pmRNSHolding(s) in Company
12th Dec 20074:35 pmRNSPrice Monitoring Extension
12th Dec 20074:00 pmRNSHolding(s) in Company
26th Nov 20075:44 pmRNSHolding(s) in Company
20th Nov 20075:45 pmRNSHolding(s) in Company
20th Nov 20074:25 pmRNSHolding(s) in Company
8th Nov 20077:00 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.